961 related articles for article (PubMed ID: 7901757)
21. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor.
Kosugi S; Shenker A; Mori T
FEBS Lett; 1994 Dec; 356(2-3):291-4. PubMed ID: 7805857
[TBL] [Abstract][Full Text] [Related]
22. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
[TBL] [Abstract][Full Text] [Related]
23. Identification of the peptides that inhibit the stimulation of thyrotropin receptor by Graves' immunoglobulin G from peptide libraries.
Park JY; Kim IJ; Lee MH; Seo JK; Suh PG; Cho BY; Ryu SH; Chae CB
Endocrinology; 1997 Feb; 138(2):617-26. PubMed ID: 9002995
[TBL] [Abstract][Full Text] [Related]
24. Further studies of amino acids (268-304) in thyrotropin (TSH)--lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: cysteine-301 is important in TSH binding and receptor tertiary structure.
Akamizu T; Inoue D; Kosugi S; Kohn LD; Mori T
Thyroid; 1994; 4(1):43-8. PubMed ID: 8054860
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
Neumann S; Krohn K; Chey S; Paschke R
Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
[TBL] [Abstract][Full Text] [Related]
26. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
[TBL] [Abstract][Full Text] [Related]
27. The first cytoplasmic loop of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
Kosugi S; Mori T
FEBS Lett; 1994 Mar; 341(2-3):162-6. PubMed ID: 8137933
[TBL] [Abstract][Full Text] [Related]
28. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
[TBL] [Abstract][Full Text] [Related]
29. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
[TBL] [Abstract][Full Text] [Related]
30. Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist.
van Zeijl CJ; van Koppen CJ; Surovtseva OV; de Gooyer ME; Plate R; Conti P; Karstens WJ; Timmers M; Saeed P; Wiersinga WM; Miltenburg AM; Fliers E; Boelen A
J Clin Endocrinol Metab; 2012 May; 97(5):E781-5. PubMed ID: 22419705
[TBL] [Abstract][Full Text] [Related]
31. Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment.
Kim WB; Cho BY; Park HY; Lee HK; Kohn LD; Tahara K; Koh CS
J Clin Endocrinol Metab; 1996 May; 81(5):1758-67. PubMed ID: 8626830
[TBL] [Abstract][Full Text] [Related]
32. A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies.
Chazenbalk GD; McLachlan SM; Pichurin P; Yan XM; Rapoport B
J Clin Endocrinol Metab; 2001 Mar; 86(3):1287-93. PubMed ID: 11238522
[TBL] [Abstract][Full Text] [Related]
33. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
[TBL] [Abstract][Full Text] [Related]
34. Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.
Hamidi S; Chen CR; McLachlan SM; Rapoport B
Thyroid; 2011 Sep; 21(9):1013-20. PubMed ID: 21834684
[TBL] [Abstract][Full Text] [Related]
35. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
36. Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies.
Latrofa F; Chazenbalk GD; Pichurin P; Chen CR; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 2004 Sep; 89(9):4734-45. PubMed ID: 15356088
[TBL] [Abstract][Full Text] [Related]
37. Possible difference in glycosylation of the thyrotropin receptor among species.
Kosugi S; Akamizu T; Mori T
Biochem Biophys Res Commun; 1994 May; 200(3):1207-13. PubMed ID: 8185569
[TBL] [Abstract][Full Text] [Related]
38. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
Kung AW; Lau KS; Kohn LD
Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
[TBL] [Abstract][Full Text] [Related]
39. A hydrophobic cluster in the center of the third extracellular loop is important for thyrotropin receptor signaling.
Claus M; Jaeschke H; Kleinau G; Neumann S; Krause G; Paschke R
Endocrinology; 2005 Dec; 146(12):5197-203. PubMed ID: 16150909
[TBL] [Abstract][Full Text] [Related]
40. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
Nagayama Y; Takeshita A; Luo W; Ashizawa K; Yokoyama N; Nagataki S
Thyroid; 1994; 4(2):155-9. PubMed ID: 7919997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
